Unidentified Analyst: Okay. And then my last question, Jess, is that lawsuit. When is it scheduled for a trial and do you have a trial date, a firm trial date? Do you have proposed settlement agreements floating around out there? When are we going to get that paying off around from our neck?
Jess Jankowski: Sure. There is not a trial date set. There’s a date at which set — which discovery has to be completed, which is the end of the year. We have been working toward, we speak regularly, just about weekly, with the BASF commercial team who was generally the people working on this — working on the settlement with us. So I have confidence that we are going to get somewhere with it. I’d love to see it behind us in the next several months, but you never know. They have — everybody has internal people to answer to, and we are — I think we are working through it in a positive way and I do think that all the indications are that they in earnest want to get through this and settle this without much further pain.
Unidentified Analyst: Okay. Well, I appreciate your answers, Jess, and of course, I wish you luck, Jess.
Jess Jankowski: Sure. Thank you, Ron.
Operator: Thank you. One moment for our next question. Our next question comes from the line of James Lieberman with Revere Securities. Your line is open.
James Lieberman: Thank you. Thank you very much. So, again, congratulations. I think actually in businesses, in general, there are all sorts of challenges that come along is how management manages through those challenges and I think you are doing a commendable job, but it’s not infrequent that you see companies that are in these transition phases finding challenges that they can’t deal with and often causes them a great deal more stress. And I thought that Ron’s question is certainly about the consolidations recovered and then also the other questions about the color on the litigation. It was helpful in a sense that it sounds like you are working through pretty much all of the things that are on your plate. So I just want you to continue doing what you are doing and rolling things out.
I was looking for possibly a little bit more consolidation of operations a little sooner, but it sounds like there’s a good reason to keep things ongoing in these various other facilities so that you can perhaps meet particular types of orders and you don’t have to manage it in one facility. So I think you are probably right, if you feel that it may — takes another year or two years or three years to get it right, you may as well get it right rather than find yourself in a position where some important elements have dropped down to the equation. So I want to congratulate you for managing through this.
Jess Jankowski: Well, thank you, Jim. I think that we shouldn’t forget, part of the reason that this is dragging out a little bit has also been we need positive results. We need to generate positive cash flow to support these things. And generally, although our — this past year hasn’t shown you the venture level returns that you want to see in an investment, in a company like Nanophase and Solésence. But the returns on moving everything into one space and the infrastructure side of it aren’t necessarily, that’s what we are winning, going back and forth with where best to invest limited resources today and I think that will become more clear as we get into next year and as we start generating the cash we need to look at all this a little more analytically versus as you know it’s been a struggle this year.
James Lieberman: No. Totally. Thank you for your guidance and your navigational skills.
Jess Jankowski: Thanks.
Operator: Thank you.
Jess Jankowski: Thanks for question.
Operator: [Operator Instructions] One moment for our next question. Our next question comes from the line of Stefano Bow [ph] with private investor. Your line is open.
Unidentified Analyst: Hello and thanks for taking my question. First one is…
Jess Jankowski: Hi.
Unidentified Analyst: … with regards to the issues — supply chain issues you had this quarter, was there something unusual compared to the other quarters or it was just the known ones like the uneven or the timing or the issues coming from the sourced — customers sourced packaging? I mean, were the usual issues or anything special that was unusual?
Jess Jankowski: Yeah. Thanks, Stefano. I think generally, some of those issues existed the external side. On the internal side, it became clear that we needed to invest more in doing the kind of the planning ahead of time. Some of the lead times and some of these things are eight weeks, 12 weeks and we had a lapse where the people responsible for that were not really — they were a little too caught up in what we need to do in the next week or two versus what we are going to need to do in September when you are sitting in June and we have gotten to a point where some of these things got backed up. We also part of that led to inefficiencies in Q3 that we are still paying for in the sense of you could produce 90% of something and have it ready to go, waiting for the last piece, whether that’s a part or a label or a box or whatever and that is not an efficient way to produce, but it is an efficient way to make sure that you are satisfying your customers as best you can.
So those are some of the issues that we had to contend with that we don’t see being an issue going into 2024. Those were a little bit on the newer side. But I think generally, the investment in the entire function is going to have benefits and help us to avoid some of the issues we have been plagued with here in the past. I also did get your note the other day about the timing on the rights offering and there will be an S-1 that gets filed.
Unidentified Analyst: Yeah.
Jess Jankowski: That will have all the detail that you are interested in and this is an example of one of those things that, I can’t always answer these questions when they come out, because we are going to share something publicly with everybody, and fortunately, your question came out a date — last night, I think, or the…
